Bayan Health vs Kin Meds
Bayan Health costs $50 less a month, and both sell semaglutide, tirzepatide and orforglipron.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Bayan Health
Best for: a priced catalog across microdose, standard, oral drop and tablet routes
Visit Bayan Health →
If you are choosing between Bayan Health and Kin Meds, the first difference is cost: Bayan Health is $50 a month cheaper at the entry price. Both prescribe semaglutide, tirzepatide and orforglipron, so moving from one to the other would not change your drug. Bayan Health leads our six-part score, 8.2 to 6.5. One of the two has an FDA warning letter on record, covered below.
Bayan Health vs Kin Meds price
Bayan Health is the cheaper way in: $99 a month against $149 a month at Kin Meds. That is $50 less each month (34% lower), or about $600 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Bayan Health ($99 a month vs $149 a month); tirzepatide is cheaper at Bayan Health ($119 a month vs $149 a month); orforglipron is cheaper at Kin Meds ($149 a month vs $269 a month).
Medications and formats
Both sell semaglutide, tirzepatide and orforglipron.
On format, Bayan Health prices compounded injections, while Kin Meds prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Kin Meds is the only one of the two with a brand-name price.
Where each one treats patients
Neither Bayan Health nor Kin Meds publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Bayan Health
Catalog: "Microdose Semaglutide GLP-1 + Vitamin B6 — $99.00 / month".
Catalog: "Semaglutide GLP-1 + Vitamin B6 — $129.00 / month".
Catalog: "Microdose Tirzepatide GLP-1/GIP + Vitamin B6 — $119.00 / month".
Catalog: "Tirzepatide GLP-1/GIP + Vitamin B6 — $149.00 / month".
Catalog: "Oral Drops Semaglutide GLP-1 — $99.00 / month".
Catalog: "Oral Drops Tirzepatide GLP-1/GIP — $119.00 / month".
Catalog: "Orforglipron Oral Tablets — $269.00 / month". The listing does not say whether this is the approved brand or a compounded preparation.
Kin Meds
$53 off first order, applied automatically at checkout per kinmeds.com/glp1-discount ('Save $53 on first order -Discount applied at checkout')
$53 off first order, auto-applied; discount page quotes starting dose 'as low as $49/week' first month
Kin Meds advertises "Starting at $149/mo" for Wegovy injection, Wegovy pill, Zepbound KwikPen, Zepbound vial and Foundayo alike. The price carries a footnote marker, but the footnote itself is missing from the site, so its conditions are unstated. Compounded semaglutide is $199 and tirzepatide $249.
Entry pricing — likely insured/savings-card tier; cash-pay LillyDirect vials run $299-$449/mo
Matches the LillyDirect $149/mo starter cash price for Foundayo
What each price covers
Bayan Health's price also covers the clinician visit, the medication itself and shipping, which Kin Meds does not claim.
Bayan Health is silent on lab work and coaching.
Kin Meds does not say what its price includes.
That matters most for the drug: unless Kin Meds confirms otherwise, budget for medication on top of its listed price.
Bayan Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Kin Meds
Inclusions not disclosed.
Where each one scores higher
Overall, Bayan Health scores 8.2 and Kin Meds 6.5 out of 10.
Bayan Health is stronger on value (10.0 vs 5.0), trust & safety (5.5 vs 3.5) and support (7.0 vs 5.0).
Effectiveness, user experience and accessibility are within half a point.
Bayan Health
8.2/10
Kin Meds
6.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Kin Meds a warning letter dated February 20, 2026 (letter 721450), and it is still open.
Bayan Health has no FDA warning letter on record with us.
Features & Coverage
| Feature | Bayan Health | Kin Meds |
|---|---|---|
| Starting Price | ✓$99/mo | $149/mo |
| Features | 5 features | ✓8 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About Bayan Health
Bayan Health publishes a full shop-style catalog rather than a plan card: microdose semaglutide and tirzepatide with B6 at $99 and $119, standard doses at $129 and $149, oral drops at $99 and $119, and Orforglipron Oral Tablets at $269. It states no memberships, no dose-based price increases and no hidden fees, and says its medications come from US 503A pharmacy partners without naming them. Its Terms name no operating entity.
Read our full Bayan Health review →About Kin Meds
Kin Meds starts compounded semaglutide at $199/mo and compounded tirzepatide at $249/mo, and carries brand-name FDA-approved options including Wegovy injection and pill, Zepbound and Foundayo from $149/mo. It is LegitScript-verified. Beyond weight loss the account also covers Sermorelin, NAD+, glutathione, TRT, hair, skin and sexual health, so members can run several protocols in one place.
Read our full Kin Meds review →Pros & Cons
Bayan Health
What we like
- Semaglutide costs $99 a month, 46% below the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $119 a month, 52% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Bayan Health
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its orforglipron, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Kin Meds
What we like
- Semaglutide costs $149 a month, 85% below the $990 median for brand-name semaglutide across the sellers we compare
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Kin Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Bayan Health wins this one, 8.2 to 6.5, above all for a priced catalog across microdose, standard, oral drop and tablet routes. It also costs $50 less each month than Kin Meds. Kin Meds fits better if oral orforglipron alongside the injectables is your priority.
Choose Bayan Health if…
You want a priced catalog across microdose, standard, oral drop and tablet routes and an opening price near $99 a month.
Choose Kin Meds if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Bayan Health vs Kin Meds: FAQ
Close alternatives to Bayan Health and Kin Meds
- Bayan Health vs PreventiveMD
- Bayan Health vs Found
- Bayan Health vs ShedRx
- Kin Meds vs Found
- Kin Meds vs PreventiveMD
- Kin Meds vs Sesame Care
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.